Do Sameiro-Faria et al. [43] suggested that higher bilirubin levels are associated with beneficial effects in HD patients by improving the lipid profile (ox-LDL, Apo A, and Apo B) and reducing inflammatory status (adiponectin, paraoxonase 1, and interleukin-6). Here, PON1 is linked to Huntington disease.